New Peptide Hubs Products Now Available
We're excited to announce that Peptide Hubs has just released a new lineup of premium research peptides, and they are now available for purchase from our International warehouse. Domestic USA stock is coming soon.
These newly launched products represent some of the most in-demand compounds within the performance-enhancement and research peptide community:
CLASSIFICATION: TARGETED FAT-LOSS PEPTIDE
ACTIVE SUBSTANCE: ADIPOTIDE (FTPP)
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: ~4 HOURS
DOSAGE: 0.25–0.5 MG/DAY (CYCLING RECOMMENDED)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): LOW RISK
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: NEUROPEPTIDE / SLEEP-REGULATING PEPTIDE
ACTIVE SUBSTANCE: DSIP
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: APPROX. 2 HOURS
DOSAGE: 100–500 MCG DAILY (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE
ACTIVE SUBSTANCE: GHRP-2
FORM: LYOPHILIZED POWDER (2 ML VIAL x 5 MG)
ACTIVE HALF-LIFE: 30 MINUTES
DOSAGE: 100–300 MCG 1–3X DAILY (RESEARCH USE)
ACNE: POSSIBLE
WATER RETENTION: MILD TO MODERATE
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GROWTH HORMONE RELEASING PEPTIDE
ACTIVE SUBSTANCE: GHRP-6
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: APPROX. 30 MINUTES
DOSAGE: 100–300 MCG PER INJECTION (RESEARCH USE)
ACNE: POSSIBLE
WATER RETENTION: MILD
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: RECOVERY & REGENERATION PEPTIDE COMPLEX
ACTIVE SUBSTANCES:
- BPC-157 10 MG
- TB-500 10 MG
- GHK-CU 50 MG
FORM: LYOPHILIZED POWDER (2 ML VIAL x 70 MG)
ACTIVE HALF-LIFE: BPC-157: ~4H, TB-500: ~1.5H, GHK-CU: ~2H
DOSAGE: 200-700 MCG PER DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: GNRH SECRETAGOGUE PEPTIDE
ACTIVE SUBSTANCE: KISSPEPTIN-10
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: APPROX. 1 HOUR
DOSAGE: 100–500 MCG/DAY (RESEARCH USE)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: ADVANCED RECOVERY & ANTI-INFLAMMATORY PEPTIDE COMPLEX
ACTIVE SUBSTANCES:
- BPC-157 10 MG
- TB-500 10 MG
- KPV 10 MG
- GHK-CU 50 MG
FORM: LYOPHILIZED POWDER (2 ML VIAL x 80 MG)
ACTIVE HALF-LIFE: BPC-157: ~4H, TB-500: ~1.5H, KPV: ~2H, GHK-CU: ~2H
DOSAGE: 250-750 MCG PER DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: MITOCHONDRIA-TARGETING PEPTIDE
ACTIVE SUBSTANCE: SS-31
FORM: LYOPHILIZED POWDER (2 ML VIAL x 50 MG)
ACTIVE HALF-LIFE: APPROX. 3–4 HOURS
DOSAGE: 10–25 MG PER WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
CLASSIFICATION: IMMUNE-MODULATING PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN ALPHA-1
FORM: LYOPHILIZED POWDER (2 ML VIAL x 10 MG)
ACTIVE HALF-LIFE: APPROX. 2 HOURS
DOSAGE: 2–6 MG PER WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: PEPTIDE HUBS
LABORATORY TESTED: VIEW LAB RESULTS
All units are part of Peptide Hubs' newest manufacturing batch, offering fresh releases with updated formulas, clean presentation, and the latest production dates.
Stay tuned for more product launches and lab updates coming shortly!
News
Wondering how to use Crypto payment methods on Dragon Pharma store ? Here is a guide on how to proceed easily with crypto payments.
It’s strong and it’s effective, like our values and our products. We have updated our website and materials to show our new Sustanon branding and we’re thrilled with the results.
In Janaury 2021, we have received a new stock of vials from Genetic Pharmaceuticals and Ice Pharmaceuticals.
Customers Feedbacks
Please leave your feedback on products or service below.
Thank you beforehand.